Back to Atlas
APotentially durableStandard research/education caution
CMP-0131
Prescription/controlled in blends
Testosterone phenylpropionate
Ergogenic / AAS
Intermediate-release testosterone anabolic-androgenic effect
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Esterified testosterone
- Primary mechanism
- Testosterone prodrug; AR agonist; A:A ratio 1:1 baseline
- Primary market use
- Androgen replacement / ester blend component
Pharmacology
- Molecular weight (Da)
- 420.59
- Oral bioavailability
- N/A (injectable ester)
- Half-life
- ~2-4 d release-dependent
- Route tags
- Route-dependent / verify
- Evidence level
- Clinical/historical
- Clinical status
- Prescription/controlled in blends
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Primarily encountered as part of testosterone blends.